HSV1 ICP4 Antikörper
Kurzübersicht für HSV1 ICP4 Antikörper (ABIN265555)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Affinity Purified
-
Reinheit
- > 95 % IgG by SDS-PAGE
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Western Blotting: > 1:600. Immunofluorescence: 1+ at 1:25.600. ELISA: 0.100 at 1:26.600
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/ml
-
Buffer
- Phosphate Buffered Saline pH 7.4 (no azide)
-
Konservierungsmittel
- Azide free
-
-
-
: "Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005834, (2016) (PubMed).
: "Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2." in: Journal of virology, Vol. 85, Issue 17, pp. 8738-51, (2011) (PubMed).
: "Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis." in: Journal of virology, Vol. 83, Issue 18, pp. 9131-9, (2009) (PubMed).
: "PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B." in: Cell, Vol. 132, Issue 6, pp. 935-44, (2008) (PubMed).
-
-
- HSV1 ICP4 (Herpes Simplex Virus Type 1 ICP4 (HSV1 ICP4))
-
Andere Bezeichnung
- HSV-1 ICP4 Immediate Early Protein (HSV-1 ICP4)
-
Substanzklasse
- Viral Protein
-
Hintergrund
- Synonyms: ICP4, IE175
Target
-